CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $28.87 ($360,821)
- 4 Open-market sale President and CEO sold 4,000 shares at an average $33.03 ($132,102)
- 4 Option exercise Chief Business Officer acquired 4,500 shares (option exercise)
- 4 Open-market sale President and CEO sold 3,500 shares at an average $28.64 ($100,224)
- 4 Open-market sale President and CEO sold 3,500 shares at $30.33 ($106,161)
- 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $39.41 ($492,678)
- 4 Open-market sale President and CEO sold 3,500 shares at an average $38.52 ($134,835)
- 4 Option exercise Chief Financial Officer acquired 20,000 shares (option exercise)
- 4 Open-market sale President and CEO sold 3,500 shares at an average $32.67 ($114,352)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 11 · 215 filings